UB Paderborn / Katalog / Suche / in CDI

Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

Alimentary pharmacology & therapeutics, 2018-09, Vol.48 (5), p.523-537

2018

Volltextzugriff (PDF)

P274 Renal failure in children with inflammatory bowel disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i640-i641

2024

Volltextzugriff (PDF)

P114 Frequent work productivity and activity impairment in caregivers of children with inflammatory bowel disease: a project of the prospective PIBD-SETQuality inception cohort study

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S206-S207

2021

Volltextzugriff (PDF)

P665 1-Year clinical and endoscopic follow-up of vedolizumab therapy in refractory PIBD patients

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S452-S452

2019

Volltextzugriff (PDF)

P116 The occurrence of venous thromboembolisms in paediatric-onset IBD

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S194-S194

2020

Volltextzugriff (PDF)

P596 An ongoing safety registry to identify rare and severe complications in children with paediatric-onset IBD

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S413-S413

2019

Volltextzugriff (PDF)

P045 TIGIT expression differentiates regulatory from inflammatory Th1 gut-homing effector CD4+ T cells in inflammatory bowel disease patients

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i161-i161

2022

Volltextzugriff (PDF)

P069 Elevated adaptive immune responses to multiple Lachnospiraceae bacterial flagellins in therapy-naïve pediatric CD patients are associated with distinct immune pathology

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i235-i236

2023

Volltextzugriff (PDF)

P021 Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S139-S139

2021

Volltextzugriff (PDF)

P012 Low frequencies of circulating inhibitory TIGIT+CD38+ effector T cells identify an immunologically distinct subgroup of pediatric patients with severe Crohn’s disease

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S134-S134

2021

Volltextzugriff (PDF)

P584 Rare and severe complications in children with paediatric-onset IBD; the international PIBD SETQuality Safety Registry by PIBDnet

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S403-S404

2018

Volltextzugriff (PDF)

P785 Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complications

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S508-S508

2018

Volltextzugriff (PDF)

P177 Prognostic factors for colectomy and acute severe colitis in paediatric ulcerative colitis: A systematic review

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S188-S188

2018

Volltextzugriff (PDF)

P283 Predicting outcomes in paediatric Crohn’s disease: A systematic review

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S244-S244

2018

Volltextzugriff (PDF)

P165 A global prospective observational study in children and adolescents with paediatric-onset IBD: the PIBD-SETQuality inception cohort

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S171-S172

2019

Volltextzugriff (PDF)

P061 Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i171-i171

2022

Volltextzugriff (PDF)

OP38 Top-down infliximab superior to step-up in children with Moderate-to-Severe Crohn’s disease: A multicentre randomised controlled trial

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S039-S039

2020

Volltextzugriff (PDF)

DOP09 IgG responses to multiple bacterial flagellins identify a subgroup of paediatric therapy-naive Crohn’s disease patients with increased microbiota-specific T-cell reactivity

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S046-S046

2020

Volltextzugriff (PDF)

Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review

NPJ digital medicine, 2022-01, Vol.5 (1), p.2-2, Article 2

2022

Volltextzugriff (PDF)

Cost-utility of an internet-based intervention with or without therapist support in comparison with a waiting list for individuals with eating disorder symptoms: a randomized controlled trial

The International journal of eating disorders, 2016-12, Vol.49 (12), p.1068-1076

2016

Volltextzugriff (PDF)

Cost-effectiveness of Internet Interventions Compared With Treatment as Usual for People With Mental Disorders: Systematic Review and Meta-analysis of Randomized Controlled Trials

Journal of medical Internet research, 2023-01, Vol.25 (2), p.e38204-e38204

2023

Volltextzugriff (PDF)

A Pharmacy-Based eHealth Intervention Promoting Correct Use of Medication in Patients With Asthma and COPD: Nonrandomized Pre-Post Study

Journal of medical Internet research, 2022-06, Vol.24 (6), p.e32396-e32396

2022

Volltextzugriff (PDF)

The feasibility and usability of a personal health record for patients with multiple sclerosis: a 2-year evaluation study

Frontiers in human neuroscience, 2024-05, Vol.18, p.1379780-1379780

2024

Volltextzugriff (PDF)

High Impact of Pediatric Inflammatory Bowel Disease on Caregivers’ Work Productivity and Daily Activities: An International Prospective Study

The Journal of pediatrics, 2022-07, Vol.246, p.95-102.e4

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

P274 Renal failure in children with inflammatory bowel disease

P114 Frequent work productivity and activity impairment in caregivers of children with inflammatory bowel disease: a project of the prospective PIBD-SETQuality inception cohort study

P665 1-Year clinical and endoscopic follow-up of vedolizumab therapy in refractory PIBD patients

P116 The occurrence of venous thromboembolisms in paediatric-onset IBD

P596 An ongoing safety registry to identify rare and severe complications in children with paediatric-onset IBD

P045 TIGIT expression differentiates regulatory from inflammatory Th1 gut-homing effector CD4+ T cells in inflammatory bowel disease patients

P069 Elevated adaptive immune responses to multiple Lachnospiraceae bacterial flagellins in therapy-naïve pediatric CD patients are associated with distinct immune pathology

P021 Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course

P012 Low frequencies of circulating inhibitory TIGIT+CD38+ effector T cells identify an immunologically distinct subgroup of pediatric patients with severe Crohn’s disease

P584 Rare and severe complications in children with paediatric-onset IBD; the international PIBD SETQuality Safety Registry by PIBDnet

P785 Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complications

P177 Prognostic factors for colectomy and acute severe colitis in paediatric ulcerative colitis: A systematic review

P283 Predicting outcomes in paediatric Crohn’s disease: A systematic review

P165 A global prospective observational study in children and adolescents with paediatric-onset IBD: the PIBD-SETQuality inception cohort

P061 Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course

OP38 Top-down infliximab superior to step-up in children with Moderate-to-Severe Crohn’s disease: A multicentre randomised controlled trial

DOP09 IgG responses to multiple bacterial flagellins identify a subgroup of paediatric therapy-naive Crohn’s disease patients with increased microbiota-specific T-cell reactivity

Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial

Cost-utility of an internet-based intervention with or without therapist support in comparison with a waiting list for individuals with eating disorder symptoms: a randomized controlled trial

Cost-effectiveness of Internet Interventions Compared With Treatment as Usual for People With Mental Disorders: Systematic Review and Meta-analysis of Randomized Controlled Trials

A Pharmacy-Based eHealth Intervention Promoting Correct Use of Medication in Patients With Asthma and COPD: Nonrandomized Pre-Post Study

The feasibility and usability of a personal health record for patients with multiple sclerosis: a 2-year evaluation study

High Impact of Pediatric Inflammatory Bowel Disease on Caregivers’ Work Productivity and Daily Activities: An International Prospective Study

Suchergebnisse filtern